Putative neuroprotective effects of caffeine in clinical trials. Concluding remarks

J Alzheimers Dis. 2010:20 Suppl 1:S249-52. doi: 10.3233/JAD-2010-01411.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Caffeine / therapeutic use*
  • Clinical Trials as Topic / methods*
  • Humans
  • Neuroprotective Agents / therapeutic use*

Substances

  • Neuroprotective Agents
  • Caffeine